Found: 2

Select item for more details and to access through your institution.

  • Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2024, v. 204, n. 2, p. 289, doi. 10.1007/s10549-023-07195-5
    By:
    • Nakhlis, Faina;
    • Niman, Samuel M.;
    • Ueno, Naoto T.;
    • Troll, Elizabeth;
    • Ryan, Sean;
    • Yeh, Eren;
    • Warren, Laura;
    • Bellon, Jennifer;
    • Harrison, Beth;
    • Iwase, Toshiaki;
    • Carisa Le-Petross, H. T.;
    • Saleem, Sadia;
    • Teshome, Mediget;
    • Whitman, Gary J.;
    • Woodward, Wendy A.;
    • Overmoyer, Beth;
    • Tolaney, Sara M.;
    • Regan, Meredith;
    • Lynce, Filipa;
    • Layman, Rachel M.
    Publication type:
    Article

  • Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00555-w
    By:
    • Garrido-Castro, Ana C.;
    • Regan, Meredith M.;
    • Niman, Samuel M.;
    • Nakhlis, Faina;
    • Remolano, Claire;
    • Rosenbluth, Jennifer M.;
    • Block, Caroline;
    • Warren, Laura E.;
    • Bellon, Jennifer R.;
    • Yeh, Eren;
    • Harrison, Beth T.;
    • Troll, Elizabeth;
    • Lin, Nancy U.;
    • Tolaney, Sara M.;
    • Overmoyer, Beth;
    • Lynce, Filipa
    Publication type:
    Article